Published in Diabetes on May 01, 1991
Glucagon-like peptide 1 improved glycemic control in type 1 diabetes. BMC Endocr Disord (2003) 1.00
Strategies for preventing type I diabetes mellitus. West J Med (1996) 0.83
Effects of cyclosporine immunosuppression in insulin-dependent diabetes mellitus of recent onset. Science (1984) 3.47
Controlled outcome evaluation of the First Step Program: a daily physical activity intervention for individuals with type II diabetes. Int J Obes Relat Metab Disord (2004) 2.54
The efficacy of acarbose in the treatment of patients with non-insulin-dependent diabetes mellitus. A multicenter controlled clinical trial. Ann Intern Med (1994) 2.08
Xylazine hydrochloridine (Rompun) overdose in man. Clin Toxicol (1979) 2.00
Immunological and pharmacological monitoring in the clinical use of cyclosporin A. Lancet (1981) 1.77
Maternal serum alpha-fetoprotein screening: report of a Canadian pilot project. CMAJ (1987) 1.72
Evaluation of cyclosporin-phenytoin interaction with observations on cyclosporin metabolites. Br J Clin Pharmacol (1984) 1.66
Cyclosporin prevents diabetes in BB Wistar rats. Lancet (1983) 1.50
Prevalence and epidemiology of toenail onychomycosis in diabetic subjects: a multicentre survey. Br J Dermatol (1998) 1.45
No relationship between carbohydrate intake and effect of acarbose on HbA1c or gastrointestinal symptoms in type 2 diabetic subjects consuming 30-60% of energy from carbohydrate. Diabetes Care (1998) 1.42
What will increase the number of organs for transplantation? Some strategies to consider. CMAJ (1994) 1.39
The effects and side effects of cyclosporine: relationship to drug pharmacokinetics. Transplant Proc (1982) 1.38
Simplified liquid-chromotographic analysis for cyclosporin A, and comparison with radioimmunoassay. Clin Chem (1983) 1.38
Continuous subcutaneous infusion of insulin in the management of diabetes mellitus. Diabetes (1980) 1.35
A randomized study comparing a patient-directed hypertension management strategy with usual office-based care. Am J Hypertens (1997) 1.27
Estradiol and testosterone secretion by human, simian, and canine testes, in males with hypogonadism and in male pseudohermaphrodites with the feminizing testes syndrome. J Clin Invest (1972) 1.23
Determinants of diet glycemic index calculated retrospectively from diet records of 342 individuals with non-insulin-dependent diabetes mellitus. Am J Clin Nutr (1994) 1.13
Cyclosporine for treatment of early type I diabetes: preliminary results. N Engl J Med (1983) 1.10
Cyclosporin A: a powerful immunosuppressant. Can Med Assoc J (1982) 1.09
Surveying physicians to determine the minimal important difference: implications for sample-size calculation. J Clin Epidemiol (1999) 1.06
Anti-donor immune responses in prediction of transplant rejection. N Engl J Med (1976) 1.04
The effects of erythromycin in patients treated with cyclosporine. Ann Intern Med (1986) 1.03
Low glycaemic index diet and disposition index in type 2 diabetes (the Canadian trial of carbohydrates in diabetes): a randomised controlled trial. Diabetologia (2008) 1.01
Day-to-day consistency in amount and source of carbohydrate intake associated with improved blood glucose control in type 1 diabetes. J Am Coll Nutr (1999) 1.00
Hormonal changes in puberty. IV. Plasma estradiol, LH, and FSH in prepubertal children, pubertal females, and in precocious puberty, premature thelarche, hypogonadism, and in a child with a feminizing ovarian tumor. J Clin Endocrinol Metab (1972) 1.00
Effects of a gold salt on lymphocyte responses. Clin Exp Immunol (1977) 0.99
Secretion of unconjugated androgens and estrogens by the normal and abnormal human testis before and after human chorionic gonadotropin. J Clin Invest (1974) 0.99
Measles antibodies as related to HL-A types in multiple sclerosis. Neurology (1976) 0.99
Development of a theory-based daily activity intervention for individuals with type 2 diabetes. Diabetes Educ (2002) 0.99
Small bowel transplantation in the dog using cyclosporine. Transplantation (1983) 0.99
Prevention and reversal of renal allograft rejection by antibody against CD45RB. Nature (1996) 0.97
HLA antigens in systemic lupus erythematosus: relationship to disease severity, age at onset, and sex. J Rheumatol (1984) 0.97
Transgenic plants expressing autoantigens fed to mice to induce oral immune tolerance. Nat Med (1997) 0.96
HLA-typing in multiple sclerosis sibling pairs. Lancet (1982) 0.95
Mechanisms of immunosuppression by cyclosporin. Transplant Proc (1981) 0.92
Cyclosporin-erythromycin interaction in normal subjects. Br J Clin Pharmacol (1987) 0.92
Hyperinsulinemia prevents prolonged hyperglycemia after intense exercise in insulin-dependent diabetic subjects. J Clin Endocrinol Metab (1994) 0.90
Glucoregulation during and after intense exercise: effects of beta-blockade. J Clin Endocrinol Metab (1994) 0.90
Regulation of the immune response. X. Antigen-antibody complex inactivation of cells involved in adoptive transfer. J Immunol (1974) 0.90
Interaction between phenytoin and cyclosporine following organ transplantation. Transplantation (1984) 0.89
Human mouse chimeric CD7 monoclonal antibody (SDZCHH380) for the prophylaxis of kidney transplant rejection. J Immunol (1993) 0.89
Small weight loss on long-term acarbose therapy with no change in dietary pattern or nutrient intake of individuals with non-insulin-dependent diabetes. Int J Obes Relat Metab Disord (1997) 0.89
The stability of utility scores: test-retest reliability and the interpretation of utility scores in elective total hip arthroplasty. Qual Life Res (2004) 0.88
Liver transplantation: the initial experience of a Canadian centre. Can J Surg (1985) 0.88
Autoimmunity: present concepts. Ann Intern Med (1975) 0.88
The Ontario trial of active compression-decompression cardiopulmonary resuscitation for in-hospital and prehospital cardiac arrest. JAMA (1996) 0.87
Advances in insulin delivery in the management of diabetes mellitus. Clin Endocrinol Metab (1982) 0.87
Histocompatibility antigens as markers of abnormal iron metabolism in idiopathic hemochromatosis. Can Med Assoc J (1978) 0.87
Cyclosporine: action, pharmacokinetics, and effect in the BB rat model. Metabolism (1983) 0.86
Organ donors in the eighties: The Ministers Task Force on Kidney Donation. Introduction. Transplant Proc (1985) 0.86
Acarbose in the treatment of elderly patients with type 2 diabetes. Diabetes Res Clin Pract (2003) 0.85
Lessons learned from use of cyclosporine for insulin-dependent diabetes mellitus. The case for immunotherapy for insulin-dependent diabetics having residual insulin secretion. Ann N Y Acad Sci (1993) 0.85
Percutaneous transluminal dilatation of transplant renal artery stenosis. Postgrad Med J (1981) 0.85
Self-awareness in diabetes: using body cues, circumstances, and strategies. Diabetes Educ (1999) 0.84
Transplantation in the 80s: a blueprint for success. Transplant Proc (1985) 0.84
Lymphocyte-dependent antibody and renal graft rejection. Lancet (1975) 0.83
Humoral and cell-mediated immunity in transfused uraemics. Proc Eur Dial Transplant Assoc (1973) 0.83
Experimental and clinical liver transplantation. Transplant Proc (1982) 0.82
Clinical and biochemical expression of the genetic abnormality in idiopathic hemochromatosis. Gastroenterology (1980) 0.82
Accuracy of capillary blood glucose values self-determined by diabetics under everyday conditions: comparison of visually-read and meter-read techniques. Clin Invest Med (1982) 0.81
Initial human pancreas transplantation and attempts to improve pancreatic duct anastomosis. Transplant Proc (1985) 0.81
Glucoregulatory and hormonal responses to repeated bouts of intense exercise in normal male subjects. J Appl Physiol (1985) (1991) 0.81
Cyclosporin for pulmonary sarcoidosis. Lancet (1984) 0.80
Cell-mediated autoimmunity in NZB mice. Clin Exp Immunol (1973) 0.80
Disappearance and reappearance of islet cell cytoplasmic antibodies in cyclosporin-treated insulin-dependent diabetics. Lancet (1985) 0.80
Temporal effect of cyclosporine immunosuppression on T lymphocyte subsets, Ia-reactive cells, and donor-specific immunity in cardiac allograft recipients. Transplant Proc (1984) 0.80
One-year acarbose treatment raises fasting serum acetate in diabetic patients. Diabet Med (1995) 0.80
Some factors indicative of hypertriglyceridemia in patients investigated for diabetes mellitus. Can Med Assoc J (1973) 0.80
Altering source or amount of dietary carbohydrate has acute and chronic effects on postprandial glucose and triglycerides in type 2 diabetes: Canadian trial of Carbohydrates in Diabetes (CCD). Nutr Metab Cardiovasc Dis (2012) 0.80
Monitoring of rejection. Transplant Proc (1979) 0.80
Insulin resistance in latent autoimmune diabetes of adulthood. Ann N Y Acad Sci (2003) 0.80
Intranasal and subcutaneous treatment of central precocious puberty in both sexes with a long-acting analog of luteinizing hormone-releasing hormone. J Clin Endocrinol Metab (1984) 0.79
The immunocompromised patient. Can Fam Physician (1987) 0.79
Use of cyclosporin a despite renal dysfunction. N Engl J Med (1981) 0.79
Lymphocyte subsets in the allograft recipient: correlation of helper to suppressor ratio with clinical events. Transplant Proc (1982) 0.79
Circulating lymphocyte subpopulations in experimental allergic neuritis. J Neuroimmunol (1984) 0.79
Interaction of bromocriptine and cyclosporine in insulin dependent diabetes mellitus: results from the Canadian open study. J Autoimmun (1990) 0.79
Inhibition of the donor-specific immune response by cyclosporin-A following renal transplantation. Transplant Proc (1981) 0.79
Fibrous hyperplasia of the gingiva: a side effect of cyclosporin A therapy. Oral Surg Oral Med Oral Pathol (1983) 0.79
Kidney transplantation. Surg Clin North Am (1986) 0.79
Inhibitory effects of gold and other drugs on mononuclear cell responses: a comparison. J Rheumatol Suppl (1979) 0.78
Quadriceps muscle function and fatigue in women with Addison's disease. Muscle Nerve (2001) 0.78
Immunosuppressive drugs in diabetes. Lancet (1986) 0.78
Acute onset of obsessive-compulsive disorder in males following childbirth. Psychosomatics (2001) 0.78
Effects of immunosuppression with cyclosporine in insulin-dependent diabetes mellitus of recent onset: the Canadian open study at 44 months. Transplant Proc (1988) 0.78
A randomized study of cyclosporine with and without prednisone in renal allograft recipients. Canadian Transplant Group. Transplant Proc (1987) 0.78
Liver-omental pouch and intrahepatic islet transplants produce portal insulin delivery and prevent hyperinsulinemia in rats. Transplant Proc (1995) 0.78
HLA-D typing with an association of Dw2 and absent immune responses towards herpes simplex (type i) antigen in multiple sclerosis. Transplant Proc (1977) 0.78
Living related donation. Transplant Proc (1985) 0.77
The effect of cyclosporine of renal function in newly diagnosed diabetics. Transplant Proc (1985) 0.77
Pharmacokinetics of cyclosporine in solid organ transplantation. Transplant Proc (1986) 0.77
Metabolic response of forearm muscle to graded exercise in type II diabetes mellitus: effect of endurance training. Can J Appl Physiol (1996) 0.77